Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis

Juan Xiao, Wenwei Liu, Yingyu Chen, Wenbin Deng

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Background: In multiple sclerosis (MS) and its widely used animal model, experimental autoimmune encephalomyelitis (EAE), autoreactive T cells contribute importantly to central nervous system (CNS) tissue damage and disease progression. Promoting apoptosis of autoreactive T cells may help eliminate cells responsible for inflammation and may delay disease progression and decrease the frequency and severity of relapse. Programmed cell death 5 (PDCD5) is a protein known to accelerate apoptosis in response to various stimuli. However, the effects of recombinant human PDCD5 (rhPDCD5) on encephalitogenic T cell-mediated inflammation remain unknown. Methods: We examined the effects of intraperitoneal injection of rhPDCD5 (10 mg/kg) on EAE both prophylactically (started on day 0 post-EAE induction) and therapeutically (started on the onset of EAE disease at day 8), with both of the treatment paradigms being given every other day until day 25. Repeated measures two-way analysis of variance was used for statistical analysis. Results: We showed that the anti-inflammatory effects of rhPDCD5 were due to a decrease in Th1/Th17 cell frequency, accompanied by a reduction of proinflammatory cytokines, including IFN-γ and IL-17A, and were observed in both prophylactic and therapeutic regimens of rhPDCD5 treatment in EAE mice. Moreover, rhPDCD5-induced apoptosis of myelin-reactive CD4<sup>+</sup> T cells, along with the upregulation of Bax and downregulation of Bcl-2, and with activated caspase 3. Conclusions: Our data demonstrate that rhPDCD5 ameliorates the autoimmune CNS disease by inhibiting Th1/Th17 differentiation and inducing apoptosis of predominantly pathogenic T cells. This study provides a novel mechanism to explain the effects of rhPDCD5 on neural inflammation. The work represents a translational demonstration that rhPDCD5 has prophylactic and therapeutic properties in a model of multiple sclerosis.

Original languageEnglish (US)
Article number117
JournalJournal of Neuroinflammation
Issue number1
StatePublished - Jun 12 2015


  • Multiple sclerosis
  • rhPDCD5
  • Th1/T17

ASJC Scopus subject areas

  • Neuroscience(all)
  • Cellular and Molecular Neuroscience
  • Neurology
  • Immunology


Dive into the research topics of 'Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis'. Together they form a unique fingerprint.

Cite this